<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>USP5 &#8211; openlabnotebooks.org</title>
	<atom:link href="https://thesgc.github.io/static-openlabnotebooks/category/project/usp5/feed/" rel="self" type="application/rss+xml" />
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<description>A growing team of groundbreaking scientists around the world are now sharing their lab notebooks online</description>
	<lastBuildDate>Mon, 01 Jul 2019 16:49:26 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.9.10</generator>

<image>
	<url>https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/01/cropped-lab-jar02-32x32.png</url>
	<title>USP5 &#8211; openlabnotebooks.org</title>
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Virtual Screening with Molecular Forecaster</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/virtual-screening-with-molecular-forecaster/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/virtual-screening-with-molecular-forecaster/#respond</comments>
		<pubDate>Wed, 19 Jun 2019 20:23:35 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2948</guid>
		<description><![CDATA[You may recall I was in Montreal for the last three months doing an internship with Molecular Forecaster Inc. (MFI), a computational chemistry company. I’m back in Toronto from my internship, ready to jump back into my research, but first I’ll summarize the virtual screening work I did at MFI for USP5. In a previous <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/virtual-screening-with-molecular-forecaster/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>You may recall I was in Montreal for the last three months doing an internship with Molecular Forecaster Inc. (MFI), a computational chemistry company. I’m back in Toronto from my internship, ready to jump back into my research, but first I’ll summarize the virtual screening work I did at MFI for USP5.</p>
<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/molecular-forecaster-inc-mfi-usp5-zf-ubd/">previous post</a>, I assessed MFI’s FITTED docking platform for ranking success on a library of experimentally tested compounds and found that flexible docking with MATCHUP resulted in the best overall ranking of USP5 ZnF-UBD compounds. I used MFI’s flexible protein docking with MATCHUP to screen large commercial libraries. You can see details on <strong><a href="https://zenodo.org/record/3250351#.XQqZg4hKjIU">Zenodo</a>. </strong></p>
<p>First, I selected commercial libraries of compounds from reliable vendors from the ZINC15 database, for at total of 607, 580 compounds. I then used REDUCE to filter the chemical library to 505, 772 compounds and SELECT to create a subset of the library by removing previously screened or experimentally tested compounds for a total of 225, 665 compounds. Finally, I used FITTED with MATCHUP to dock the ligands to USP5 ZnF-UBD. Since the library of compounds I was screening was large (&gt;225K compounds), I relied on the docking scores generated by FITTED to compile a list of 347 ligands that had the best docking scores (Figure 1).</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619a-300x141.png" alt="" width="600" height="282" class="wp-image-2949 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619a-300x141.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619a-768x361.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619a-1024x481.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619a.png 1590w" sizes="(max-width: 600px) 100vw, 600px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Summary of virtual screening workflow</p>
<p>A large majority of the top scoring ligands are small fragments, with carboxylate groups, which is not surprising considering the carboxylate group mimics the native C-terminus of ubiquitin which binds to the USP5 ZnF-UBD. I will look through the list of top scoring ligands and determine if there are any favorable scaffolds with new binding pocket interactions that might improve potency. For example, ZINC000000376528 makes hydrogen bonds with Y261, R221 backbone and side chain, similar to hits we have seen before (PDB: 6DXT, 6NFT, 6DXH). Interestingly, an amino group makes hydrogen bond interactions with D264. It is possible that this additional hydrogen bond interaction, which has not been seen in previous hits could improve potency. It may also be possible to engineer existing hits with this group, if this is the case.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619b-300x285.png" alt="" width="368" height="350" class="wp-image-2950 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619b-300x285.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/06/20190619b.png 453w" sizes="(max-width: 368px) 100vw, 368px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Docked pose of ZINC000000376528 (magenta) and co-crystallized ligand PDB: 6DXH (cyan)</p>
<p>This week will be busy, planning and organising future work as well as selecting potential new scaffolds for ordering. I also have the University of Toronto’s 2019 Visions in Pharmacology (VIP) research day this week, for which I’ll be doing a poster presentation on my work with USP5. I’m looking forward to hearing about the research being done by other students in my department. Stay tuned!</p>
<table data-upload-id="file_upload:94847dd1-9b0f-4d47-ae6a-1fccc79b55c1">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO</td>
<td>196.2</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C([O-])[C@H](O)[C@H](O)CO</td>
<td>135.1</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>OC[C@@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O</td>
<td>342.3</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>N[C@@H](C[C@@H](O)C(=O)O)C(=O)O</td>
<td>163.1</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>N[C@H](CCS(=O)(=O)O)C(=O)O</td>
<td>183.2</td>
</tr>
</tbody>
</table>
<p><a href="/wp-content/uploads/2019/07/2948_2e7b87d5-8f87-4263-b38a-1740929da85c.sdf">Download SDF file</a></p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/virtual-screening-with-molecular-forecaster/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Testing Selectivity of USP5 Zf-UBD Analogues with SPR Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/testing-selectivity-of-usp5-zf-ubd-analogues-with-spr-assay/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/testing-selectivity-of-usp5-zf-ubd-analogues-with-spr-assay/#respond</comments>
		<pubDate>Wed, 08 May 2019 16:21:03 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2827</guid>
		<description><![CDATA[In a previous post, I tested hit analogues and found compound XSR00035795a (Figure 1) had increased potency and ligand efficiency; however, compound XSR00035795a was also found to bind to HDAC6 Zf-UBD, so it was not selective towards USP5. Figure 1. XSR00035795a We hypothesized that it was possible to extend the aliphatic group on the carboxylic <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/testing-selectivity-of-usp5-zf-ubd-analogues-with-spr-assay/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/">previous post,</a> I tested hit analogues and found compound XSR00035795a (Figure 1) had increased potency and ligand efficiency; however, compound XSR0003<span style="font-size: 1.5rem;">5795a was also found to bind to HDAC6 Zf-UBD, so it was not selective towards USP5.</span></p>
<p style="text-align: center;"><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425b-300x82.png" alt="" width="428" height="117" class="wp-image-2828 aligncenter" style="font-size: 1.5rem;" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425b-300x82.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425b.png 515w" sizes="(max-width: 428px) 100vw, 428px" /><strong>Figure 1</strong>. XSR000<span style="font-size: 1.5rem;">35795a</span></p>
<p>We hypothesized that it was possible to extend the aliphatic group on the carboxylic chain to further increase potency and potentially improve selectivity towards USP5 Zf-UBD. We ordered and tested these compounds- experimental details can be found on<a href="https://zenodo.org/record/2677941#.XNL_W-hKjIU"><strong> Zenodo. </strong></a></p>
<p>Unfortunately, the follow-up co<span style="font-size: 1.5rem;">mpounds with extended aliphatic groups on the carboxylic chain showed no significant binding (KD &gt;1 mM) to USP5; the extension of the methyl group does not seem to be tolerated (Figure 2).  </span></p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425a-300x129.png" alt="" width="344" height="148" class="wp-image-2829 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425a-300x129.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425a-768x330.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425a-1024x439.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190425a.png 1151w" sizes="(max-width: 344px) 100vw, 344px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Binding curve of compound F3341-0338 (no binding)</p>
<p>Next, we’ll be looking for different compounds scaffolds through a larger virtual screen using Molecular Forecaster’s FITTED docking platform.</p>
<p>On another note, a chemical functionality feature is being introduced to the open lab notebook platform. This feature will allow users to upload SDF files or draw chemical structures and readers will be able to make substructure searches against all future notebook records (Figure 3).</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190508a-300x132.png" alt="" width="507" height="223" class="wp-image-2832 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190508a-300x132.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190508a-768x338.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190508a-1024x451.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/05/20190508a.png 1596w" sizes="(max-width: 507px) 100vw, 507px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Substructure Search function on the openlabnotebooks.org website</p>
<p>I&#8217;ve uploaded an SDF file of the compounds I tested in this experiment. A few of the compounds and pertinent information (SMILES and molecular weight) can be seen below.</p>
<table data-upload-id="file_upload:01e38e2e-de61-46c8-a993-4dbfd9650b6c">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CC(C(=O)O)n1c(=S)[nH]c2ccccc2c1=O</td>
<td>250.3</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>C=C1Nc2ccccc2C(=O)N1C(C)C(=O)O</td>
<td>232.2</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CC(C(=O)O)n1cnc2ccccc2c1=O</td>
<td>218.2</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CC(C)C(C(=O)O)n1cnc2ccccc2c1=O</td>
<td>246.3</td>
</tr>
</tbody>
</table>
<p><a href="/wp-content/uploads/2019/07/2827_2a996831-730a-4890-99f5-8d30b9e31283.sdf">Download SDF file</a></p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/testing-selectivity-of-usp5-zf-ubd-analogues-with-spr-assay/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular Forecaster Inc (MFI): USP5 Zf-UBD</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/molecular-forecaster-inc-mfi-usp5-zf-ubd/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/molecular-forecaster-inc-mfi-usp5-zf-ubd/#respond</comments>
		<pubDate>Mon, 01 Apr 2019 12:30:17 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2625</guid>
		<description><![CDATA[In my last post, I mentioned I would be doing an internship at a biotech company in Montreal, Molecular Forecaster Inc as a part of a NSERC ChemNet CREATE grant. I’ve been in Montreal for about three weeks now and have had a chance to play around with the Forecaster software. I did preliminary docking <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/molecular-forecaster-inc-mfi-usp5-zf-ubd/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In my last post, I mentioned I would be doing an internship at a biotech company in Montreal, Molecular Forecaster Inc as a part of a NSERC ChemNet CREATE grant. I’ve been in Montreal for about three weeks now and have had a chance to play around with the Forecaster software. I did preliminary docking validation studies for USP5 Zf-UBD using the Forecaster FITTED program. You can find experimental details on <a href="https://zenodo.org/record/2620208#.XKIBqihKiUk">Zenodo</a>.</p>
<p>First, I did self-docking studies with USP5 Zf-UBD co-crystal structures to assess the success of ligand docking. Self-docking is a method where a ligand is docked into the protein structure it was extracted from. To evaluate the correctness of the predicted pose, root mean square deviation values (RMSD) are evaluated; the lower the RMSD, the better the docked pose. The predicted binding poses of self-docked ligands was successful (RMSD &lt;2 Å), as shown in Figure 1.</p>
<p><img class=" wp-image-2629 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401b-300x187.png" alt="" width="412" height="257" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401b-300x187.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401b.png 468w" sizes="(max-width: 412px) 100vw, 412px" /></p>
<p style="text-align: center;"><strong>Figure 1.</strong> USP5 Zf-UBD self-docking RMSD</p>
<p>An interesting aspect of the Forecaster platform is MATCHUP, where you can dock ligands to a protein and simulate the flexibility of the protein by providing several conformations of structures. The predicted binding poses of ligands docked using MATCHUP was also successful (RMSD &lt;2 Å), as shown in Figure 2, however the docked poses of compound DAT201 and compound DAT180 had higher RMSDs (RMSD &gt;1.5 Å) with flexible docking than rigid self-docking (Figure 3).</p>
<p><img class=" wp-image-2630 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401c-300x168.png" alt="" width="447" height="250" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401c-300x168.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401c.png 536w" sizes="(max-width: 447px) 100vw, 447px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Self-docking (rigid) vs. flexible docking (MATCHUP)</p>
<p>&nbsp;</p>
<p><img class=" wp-image-2628 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401a-300x148.png" alt="" width="527" height="260" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401a-300x148.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401a-768x380.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401a-1024x506.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401a.png 1456w" sizes="(max-width: 527px) 100vw, 527px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Flexible docked pose (green) versus co-crystallized ligand (grey) a) DAT201 b) DAT180 c) DAT194</p>
<p>I also performed rigid cross-docking of the available USP5 Zf-UBD structures. Cross-docking is when different ligands are docked to a protein structure from a complex; this is useful when deciding which structure to use for virtual screening. Table 1 summarizes the results of the cross-docking study, where structure 6NFT had the best overall average RMSD.</p>
<p style="text-align: center;"><strong>Table 1</strong>. Cross-docking: RMSDs of ligand pose with best energy complex from 3 poses</p>
<p><img class="alignnone wp-image-2631 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401d-300x91.png" alt="" width="333" height="101" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401d-300x91.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401d.png 444w" sizes="(max-width: 333px) 100vw, 333px" /></p>
<p>Lastly, I did a virtual screen of a library of USP5 Zf-UBD compounds that have already been experimentally tested to determine the best ranking docking method (Figure 3). Flexible docking with MATCHUP results in the best overall ranking of USP5 Zf-UBD compounds, when comparing ligand activity and docking scores, as shown by the area under the curve (AUC) values. The AUC of the docking methods are marginally better than random (Figure 3-red (AUC=0.5)) which may be because all compounds in the library tested, include a carboxylic chain that drives binding in the pocket, making it challenging to distinguish between active and inactive ligands. Next, I’ll be using Forecaster’s flexible protein docking with MATCHUP to screen larger commercial libraries in the search for different ligand scaffolds against USP5 Zf-UBD. Stay tuned!</p>
<p><img class=" wp-image-2632 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401e-300x40.png" alt="" width="353" height="47" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401e-300x40.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401e.png 476w" sizes="(max-width: 353px) 100vw, 353px" /></p>
<p><img class=" wp-image-2633 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401f-300x174.png" alt="" width="445" height="258" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401f-300x174.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/04/20190401f.png 624w" sizes="(max-width: 445px) 100vw, 445px" /></p>
<p style="text-align: center;"><strong>Figure 3. </strong>ROC of virtual screen of USP5 Zf-UBD compounds</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><u>References </u></p>
<p>Corbeil C.R., Englebienne P., Moitessier N. Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0<strong> </strong><em>J. Chem. Inf. Model.</em> (2007), 47, 2, 435-449</p>
<p>Corbeil C.R., Moitessier N. Docking ligands into flexible and solvated macromolecules. 3. Impact of input ligand conformation, protein flexibility, and water molecules on the accuracy of docking programs<strong> </strong><em>J. Chem. Inf. Model.</em> (2009), 49, 4, 997-1009</p>
<p>Moitessier N., Pottel J., Therrien E., Englebienne P., Liu Z., Tomberg A., Corbeil C.R. Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods <em>Acc. Chem. Res.</em> (2016), 49 (9), 1646-1657</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/molecular-forecaster-inc-mfi-usp5-zf-ubd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USP5 Zf-UBD Co-Crystal Structure with Compound XSR00035795a &#038; Testing Selectivity</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/#respond</comments>
		<pubDate>Fri, 01 Mar 2019 19:24:16 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2548</guid>
		<description><![CDATA[In a previous post, I tested hit analogues against USP5 Zf-UBD using a SPR assay. Compound AE-641/11456811, now aptly re-named XSR00035795a (an SGC global ID- since our database infrastructure is finally re-vamped), had a binding affinity of approximately 60 µM. The addition of a methyl group on the carboxylic chain of the compound increased potency <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/">previous post</a>, I tested hit analogues against USP5 Zf-UBD using a SPR assay. Compound AE-641/11456811, now aptly re-named XSR00035795a (an SGC global ID- since our database infrastructure is finally re-vamped), had a binding affinity of approximately 60 µM. The addition of a methyl group on the carboxylic chain of the compound increased potency 3-fold!</p>
<p>You can find details of this experiment on <a href="https://zenodo.org/record/2581522#.XHmFHIhKjIU">Zenodo</a>. I crystallized the complex of USP5 Zf-UBD with XSR00035795a, and the structure was solved by Dr. Wolfram Tempel. The addition of the methyl group leads to increased hydrophobic interactions in the binding pocket with W209; the side chain of R221 also rotates out of the pocket (Figure 1).</p>
<p><img class="wp-image-2549 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301e-300x122.png" alt="" width="585" height="237" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301e-300x122.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301e-768x313.png 768w" sizes="(max-width: 585px) 100vw, 585px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. a) Superimposed USP5 structures of compound DAT194 (PDB: 6NFT; cyan) and compound XSR00035795a (magenta) b) Binding pocket of co-crystal structure of USP5 Zf-UBD and XSR00035795a</p>
<p>Next, I tested this compound against HDAC6 Zf-UBD to see if it confers selectivity against USP5 Zf-UBD using a SPR assay (Figure 2). Compound XSR00035795a (LE=0.36) was not selective for USP5 Zf-UBD. XSR00035795a and HDAC6 Zf-UBD has a K<sub>D</sub> of 15 ± 0.4 µM (n=2) whereas USP5 Zf-UBD has an average K<sub>D</sub> of 60 ± 8 µM (n=3).</p>
<p style="text-align: left;">a)                                                                                                        b)<img class="wp-image-2550 alignnone" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-300x75.png" alt="" width="648" height="162" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-300x75.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-768x193.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-1024x257.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f.png 1372w" sizes="(max-width: 648px) 100vw, 648px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Representative SPR binding curves and sensograms of compound XSR00035795a with a) HDAC6 Zf-UBD (K<sub>D</sub>= 15 ± 0.4 µM; n=2) and b) USP5 Zf-UBD (K<sub>D</sub>= 60 ± 8 µM; n=3)</p>
<p>When co-crystal structures of HDAC6 Zf-UBD and USP5 Zf-UBD are superimposed, binding of XSR00035795a to HDAC6 Zf-UBD makes sense. Figure 3 shows the binding pocket of HDAC6 Zf-UBD is able to accommodate the methyl group of compound XSR00035795a. Replacing a valine residue in the primary pocket of HDAC6 with an alanine in USP5 generates a small cavity that may be exploited by extending the aliphatic group on the carboxylic chain to confer selectivity towards USP5.</p>
<p><img class=" wp-image-2551 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-300x226.png" alt="" width="448" height="336" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-300x226.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-350x263.png 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-250x188.png 250w" sizes="(max-width: 448px) 100vw, 448px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Superimposed CPK representation of HDAC6 Zf-UBD (purple PDB: 6CE8) and USP5 Zf-UBD and compound XSR00035795a co-crystal structure (cyan)</p>
<p>Commercial compounds with extended aliphatic groups on the scaffold have been ordered but unfortunately due to vendor delays, I haven’t received them! Here’s hoping the compounds will arrive soon…</p>
<p>On another note, I will be doing a three month internship at the Montreal biotech, Molecular Forecaster Inc., as part of a NSERC-CREATE ChemNET grant. I will further explore computational chemistry approaches and structure-based drug design to design inhibitors against USP5 Zf-UBD and use the docking platform to dock compounds against available subfamily protein domain structures, as a predictive tool for selectivity. I’ll be heading to Montreal next week! Stay tuned for some neat computational simulations against USP5 Zf-UBD and the results of the extended aliphatic groups on the XSR00035795a scaffold.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Testing Hit Analogues against USP5 Zf-UBD with SPR Assay #1</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/#respond</comments>
		<pubDate>Thu, 24 Jan 2019 15:34:40 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2393</guid>
		<description><![CDATA[In a previous post, I described using hit expansion tools such as commercial substructure searches, docking, and free energy perturbation (FEP) simulations to explore the structure activity relationship (SAR) of the chemical series focused on the Zf-UBD of USP5. The first batch of commercially ordered compounds arrived just before the Christmas holidays. I decided to <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/">previous post</a>, I described using hit expansion tools such as commercial substructure searches, docking, and free energy perturbation (FEP) simulations to explore the structure activity relationship (SAR) of the chemical series focused on the Zf-UBD of USP5. The first batch of commercially ordered compounds arrived just before the Christmas holidays. I decided to tackle testing the chemical analogues in the New Year. I used a surface plasmon resonance (SPR) assay to determine binding affinities of commercially ordered analogues, designed from compounds hits listed in Table 1. You can see details on <a href="https://zenodo.org/record/2548710#.XEnZclxKjIU">Zenodo</a><strong>. </strong></p>
<p style="text-align: left;"><strong>Table 1</strong>. Compound Hits from which chemical analogues were designed</p>
<p><img class="wp-image-2394 alignleft" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124a-300x153.png" alt="" width="451" height="231" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124a-300x153.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124a.png 678w" sizes="(max-width: 451px) 100vw, 451px" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Of the 19 analogues tested, compound AE-641/11456811, an analogue of DAT194 (K<sub>D</sub>= 215 µM; n=9) had a binding affinity of approximately 65 µM (n=6) and an excellent ligand efficiency of 0.36 (Figure 1). The addition of a methyl group increased potency 3-fold!</p>
<p><img class=" wp-image-2395 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-300x83.png" alt="" width="473" height="131" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-300x83.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-768x212.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-780x218.png 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b.png 788w" sizes="(max-width: 473px) 100vw, 473px" /></p>
<p style="text-align: center;">Figure 1. A) Compound DAT194 B) Compound AE-641/11456811</p>
<p>Compound DAT194 (PDB: 6NFT) and the docked pose of AE-641/11456811 are shown in Figure 2a. The addition of the methyl group leads to increased hydrophobic interactions in the binding pocket with W209. In Figure 2b, the docked pose of AE-641/11456811 shows the methyl group fits into a small groove in the pocket. Based on the docked pose, it may be possible to further extend the non-polar group into the pocket to increase the potency further. For this reason, compounds in Figure 3 were ordered as follow up compounds of AE-641/11456811.</p>
<p><img class="wp-image-2396 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c-300x101.png" alt="" width="529" height="178" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c-300x101.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c-768x258.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c.png 900w" sizes="(max-width: 529px) 100vw, 529px" /></p>
<p style="text-align: center;"><strong>Figure 2.</strong> A) Compound DAT194 (PDB: 6NFT) in magenta and docked pose of AE-641/11456811 (yellow) B) Binding pocket of USP5 Zf-UBD and docked pose AE-641/11456811 (yellow)</p>
<p><img class=" wp-image-2397 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124d-300x181.png" alt="" width="290" height="175" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124d-300x181.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124d.png 708w" sizes="(max-width: 290px) 100vw, 290px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Follow up compounds of AE-641/11456811</p>
<p>Analogues of DAT180 and DAT201 that were tested did not show a significant improvement in potency. So far, I’ve tested 19 of the 39 analogue compounds of DAT180, DAT194 and DAT201 that were selected in the hit expansion. Some compounds required custom synthesis and were not ordered, and others are still in transit. I will be testing the rest of the analogues once the next batch of compounds arrive, as well as testing follow up compounds of AE-641/11456811. I’ll also be setting up co-crystal trays of USP5 Zf-UBD and AE-641/11456811 for structure determination. Stay tuned!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USP Zf-UBD Crystallography Pipeline Pt 2.</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/#respond</comments>
		<pubDate>Fri, 14 Dec 2018 22:28:00 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2266</guid>
		<description><![CDATA[In a previous post, I described the importance of solving the structure of other USPs that have a Zf-UBD for the rational design of selective compounds. The last post described the design, cloning, E.coli expression, growth and purification of some of the USP Zf-UBD constructs. As a continuation in my quest to try and crystallize <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a previous <a href="https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/">post</a>, I described the importance of solving the structure of other USPs that have a Zf-UBD for the rational design of selective compounds. The last post described the design, cloning, <em>E.coli </em>expression, growth and purification of some of the USP Zf-UBD constructs. As a continuation in my quest to try and crystallize the other USP Zf-UBDs I’ve finished purifying and setting up crystallization screens of the ‘TOC013’ constructs in an attempt to crystallize these protein samples for subsequent structure determination by X-ray crystallography. You can see details on <a href="https://zenodo.org/record/2284636#.XBQt_lxKiUk"><strong>Zenodo</strong></a>.  I previously described getting crystals of USP33 that did not diffract and USP20 microcrystals that were too small to mount. I tried ‘seeding’ these initial crystal conditions in the hopes of getting larger crystals that diffract. Micro-seeding is the process of adding a dilute solution of m<span style="font-size: 1.5rem;">icro-crystals to a crystallizing solution to nucleate more crystals. This helps in controlling size and reproducibility.</span></p>
<p>So far, I have not had any luck with seeding but it may just be a matter of time- some proteins take longer to crystallize than others. I’ll have to keep an eye on my plates. Hopefully I’ll have some luck in the New Year and come back to crystals after the holidays! The USP Zf-UBD crystallization pipeline to date is summarized in Table 1.</p>
<p style="text-align: center;"><strong>Table 1</strong>. Summary of USP Zf-UBD Crystallization</p>
<table style="height: 2843px;" width="694">
<tbody>
<tr>
<td style="width: 73.9205px;"><strong>Clone </strong></td>
<td style="width: 41.1932px;"><strong>Target</strong></td>
<td style="width: 26.6477px;"><strong>AA </strong></td>
<td style="width: 43.0114px;"><strong>Vector</strong></td>
<td style="width: 37.5568px;"><strong>Media</strong></td>
<td style="width: 49.375px;"><strong>Amount Grown (L)</strong></td>
<td style="width: 72.1023px;"><strong>Purification Yield (mg) </strong></td>
<td style="width: 44.8295px;"><strong>Crystal Plate Setup (Y/N) </strong></td>
<td style="width: 84.8295px;"><strong>Crystals? (Y/N) </strong></td>
<td style="width: 65.7386px;"><strong>Diffraction (Y/N)</strong></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013E09</td>
<td style="width: 41.1932px;">USP44</td>
<td style="width: 26.6477px;">27-110</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">12</td>
<td style="width: 72.1023px;">No/low expression</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013F02</td>
<td style="width: 41.1932px;">USP49</td>
<td style="width: 26.6477px;">15-105</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">12</td>
<td style="width: 72.1023px;">0.25 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D10</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">37-124</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">15.7 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">Y</p>
<p>-seeding:100 nL of 1:1000 and 1:10000 SM of 1 µL drops of RWD01, RWE01, SGCF03 small microcrystals (SM concentration too high?)</td>
<td style="width: 65.7386px;">N</td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D11</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">38-124</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">0.35 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013E02</td>
<td style="width: 41.1932px;">USP39</td>
<td style="width: 26.6477px;">97-197</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">1.6 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013E05</td>
<td style="width: 41.1932px;">USP39</td>
<td style="width: 26.6477px;">97-205</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">1.1 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C02</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">188-292</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">Insoluble</td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C03</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">208-292</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">Insoluble</td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C04</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">208-308</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">2.4 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013B11</td>
<td style="width: 41.1932px;">USP03</td>
<td style="width: 26.6477px;">10-152</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">2 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C08</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">26-146</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">0.7 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C09</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">32-146</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">0.8 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C11</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">1-100</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">4.8 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D03</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">1-110</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">13.2 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">Y: small microcrystals SGCC08</p>
<p>&nbsp;</p>
<p>optimizing:</p>
<p>1) different protein concentrations (1, 2, 3, 4 mg/mL); no crystals</p>
<p>2) seeding with SGCC08; no crystals</p>
<p>&nbsp;</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D04</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">8-110</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">7.2 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013-D07</td>
<td style="width: 41.1932px;">USP22</td>
<td style="width: 26.6477px;">43-142</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">No/low expression</td>
<td style="width: 44.8295px;">N</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D08</td>
<td style="width: 41.1932px;">USP22</td>
<td style="width: 26.6477px;">49-142</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">No/low expression</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;"></td>
<td style="width: 41.1932px;"></td>
<td style="width: 26.6477px;"></td>
<td style="width: 43.0114px;"></td>
<td style="width: 37.5568px;"></td>
<td style="width: 49.375px;"></td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 708.466px;" colspan="10">Constructs previously available in SGC database that have high expression:</td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC093D04</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">183-307</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">26.3 mg</td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC093D05</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">187-301</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC024F07</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">34-185</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC024F09</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">16-185</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC024F10</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">8-185</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC036B06</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">1-141</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC042G05</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">7-139</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC042G06</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">7-167</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC042G07</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">7-183</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC168E10</td>
<td style="width: 41.1932px;">USP44</td>
<td style="width: 26.6477px;">1-167</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC231F11</td>
<td style="width: 41.1932px;">USP51</td>
<td style="width: 26.6477px;">160-350</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC231-G03</td>
<td style="width: 41.1932px;">USP51</td>
<td style="width: 26.6477px;">176-350</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Development of a Mass Spectrometry USP5 Catalytic Activity Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/#respond</comments>
		<pubDate>Fri, 23 Nov 2018 17:04:50 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2182</guid>
		<description><![CDATA[Now that I’ve got my biophysical screening assays developed (19F NMR, SPR), as well as my hit expansion campaign started for small molecule inhibitors against the USP5 Zf-UBD, I need to be able to test if these small molecule inhibitors will antagonize the catalytic activity of USP5. It has been speculated in literature that the <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Now that I’ve got my biophysical screening assays developed (<a href="https://thesgc.github.io/static-openlabnotebooks/compounds-of-interest-identified-by-screening-a-focused-library-against-usp5-zf-ubd-with-a-19f-nmr-assay/">19F NMR</a>, <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">SPR</a>), as well as my<a href="https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/"> hit expansion campaign</a> started for small molecule inhibitors against the USP5 Zf-UBD, I need to be able to test if these small molecule inhibitors will antagonize the catalytic activity of USP5.</p>
<p>It has been speculated in literature that the Zf-UBD is responsible for substrate recruitment, substrate positioning for proper conformation for cleavage, and that binding of ubiquitin at the Zf-UBD allosterically activates catalytic cleavage; however, the exact function of the Zf-UBD is still unclear. Perhaps, the Zf-UBD is more important for the cleavage of some substrates than others. For this reason, I need an assay that will work with diverse substrates to elucidate the function of the Zf-UBD in regards to catalytic activity.</p>
<p>I was able to express and purify full length USP5 and SGC’s Dr. Suzanne Ackloo developed and optimized a mass spectrometry (MS) assay to detect polyubiquitin cleavage. You can see full experimental details on <a href="https://zenodo.org/record/1495189#.W_gyzuhKjIU">Zenodo</a>. Mass spectrometry is an analytical tool used to sort ions on the basis of their mass-charge ratio; this allows for the measurements of masses within a sample. Before the reaction begins I am able to see a clear intensity of the substrate, a tetra-ubiquitin species (Ub4K63). After the addition of USP5, over time the tetra-ubiquitin (Ub4) is cleaved into tri, di and mono-ubiquitin (Ub3, Ub2, Ub1) (<strong>Figure 1</strong>).</p>
<p>&nbsp;</p>
<p><img class="wp-image-2183 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a-300x171.png" alt="" width="567" height="323" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a-300x171.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a-768x437.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a.png 927w" sizes="(max-width: 567px) 100vw, 567px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Mass spectra of a) Substrate Ub4K63 b) 20 ng USP5 reaction at 1 hour</p>
<p>Next, I’ll be testing some of the small molecule inhibitors of the zinc-finger ubiquitin binding domain (Zf-UBD) in the mass spectrometry assay to determine if the small molecules can antagonize the catalytic activity of USP5.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hit Expansion using Substructure Search, Virtual Screening &#038; Free Energy Perturbation</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/#respond</comments>
		<pubDate>Fri, 16 Nov 2018 18:09:30 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2155</guid>
		<description><![CDATA[Molecular dynamic simulations are a powerful tool for modeling biomolecular systems such as ligand binding to proteins. In a previous post I was able to get co-crystal structures of ligands which bind to the USP5 zinc finger ubiquitin binding domain (Zf-UBD). In order to explore the structure activity relationship (SAR) of the chemical series, so <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Molecular dynamic simulations are a powerful tool for modeling biomolecular systems such as ligand binding to proteins. In a previous <a href="https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/">post</a> I was able to get co-crystal structures of ligands which bind to the USP5 zinc finger ubiquitin binding domain (Zf-UBD). In order to explore the structure activity relationship (SAR) of the chemical series, so I can rationally design more potent ligands, I used MolPort and Emoleules to find chemically related, commercially available molecules, and then used free energy perturbation (FEP) to prioritize compound ordering. You can see full experimental details on <a href="https://zenodo.org/record/1490065#.W-8GzOhKjIU">Zenodo</a><strong>. </strong>Free energy perturbation (FEP) is a computational chemistry tool that allows for the thermodynamic calculation of relative binding free energy<sup>1</sup>. The binding free energy difference can be calculated by the difference of the free energy of transforming ligand 1 to ligand 2 in the solvent and in complex with a receptor (<strong>Figure 1</strong>)<sup>1</sup>.</p>
<p><img class="size-medium wp-image-2156 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116a-297x300.png" alt="" width="297" height="300" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116a-297x300.png 297w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116a.png 373w" sizes="(max-width: 297px) 100vw, 297px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Thermodynamic pathway of calculating the free energy difference<sup>1</sup></p>
<p>As an example, for DAT180, I did a substructure search using constraints on the aromatic rings as well as the carboxyl group of the compound which was shown to be an important interaction in the co-crystal structure. I got a few hundred hits which I docked to the Zf-UBD while imposing H-bonding constraints between the R221/Y261, and the carboxylate of the compound, important interactions in the binding pocket (<strong>Figure 2</strong>).</p>
<p><img class="size-medium wp-image-2157 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116b-300x194.png" alt="" width="300" height="194" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116b-300x194.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116b.png 517w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Co-crystal structure of USP5 Zf-UBD and DAT180 (PDB: 6DXT)</p>
<p>After docking, 30 compounds were selected on the basis of visual inspection &amp; chemistry intuition, molecular weight, and docking scores. I used FEP as a tool to estimate the free energy difference of analogues of the ligands from the co-crystal structures that bind with micromolar affinity, as shown by <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">SPR</a>, for a final selection of 17 compounds (<strong>Figure 3</strong>).</p>
<p><img class=" wp-image-2158 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c-300x96.png" alt="" width="438" height="140" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c-300x96.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c-768x246.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c.png 917w" sizes="(max-width: 438px) 100vw, 438px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Hit expansion summary of DAT180</p>
<p>I’ve ordered the selected compounds from the substructure searches/FEP. Hopefully, the next batch of compounds I test experimentally will have increased potency. More on this soon!</p>
<p>&nbsp;</p>
<p><sup>1</sup><em>Acc. Chem. Res.</em>, <strong>2017</strong>, <em>50</em> (7), pp 1625–1632</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USP Zf-UBD Crystallography Pipeline</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/#respond</comments>
		<pubDate>Mon, 29 Oct 2018 14:18:47 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2064</guid>
		<description><![CDATA[X-ray crystallography is a tool used for the structural determination of proteins and biological molecules. My specific project focuses on the zinc finger ubiquitin binding domain (Zf-UBD) of USP5; however, USP5 is just one of many USPs that contain a Zf-UBD. Table 1 shows a list of the USP Zf-UBDs and their available structures in <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>X-ray crystallography is a tool used for the structural determination of proteins and biological molecules. My specific project focuses on the zinc finger ubiquitin binding domain (Zf-UBD) of USP5; however, USP5 is just one of many USPs that contain a Zf-UBD. <strong>Table 1</strong> shows a list of the USP Zf-UBDs and their available structures in the protein data bank (PDB).  In addition, the protein BRAP also has a Zf-UBD. My recently identified USP5 inhibitors are far from being optimized, but my goal is to find compounds that are potent and selective for USP5 and that can be used by cell-biologists. I will need to test them against other Zf-UBD’s to determine their specificity. Crystal structures of other Zf-UBD’s will be useful to rational design selective compounds.</p>
<p><strong>Table 1</strong>. USP Zf-UBDs &amp; Available PDB Structures</p>
<table style="height: 869px; width: 235px;" width="334">
<tbody>
<tr>
<td style="width: 105.527px;"><strong>Target Zf-UBD </strong></td>
<td style="width: 91.7773px;"><strong>PDB ID </strong></td>
</tr>
<tr>
<td style="width: 105.527px;">USP3</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP5</td>
<td style="width: 91.7773px;">2G43 (X-ray)</p>
<p>2G45 (X-ray)</p>
<p>3IHP (X-ray)</p>
<p>6DXH (X-ray)</p>
<p>6DXT (X-ray)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP13</td>
<td style="width: 91.7773px;">2L80 (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP16</td>
<td style="width: 91.7773px;">2I50 (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP20</td>
<td style="width: 91.7773px;">5Z4I (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP22</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP33</td>
<td style="width: 91.7773px;">2UZG (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP39</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP44</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP45</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP49</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP51</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
</tbody>
</table>
<p>I designed constructs of the different USP Zf-UBDs through analysis of the available structures and by using secondary structure prediction tools. Peter Loppnau, SGC’s cloning expert ordered primers and cloned my constructs into expression vector pET28-MHL to allow expression and purification from bacterial production. Linda Lin, another talented colleague, then did a test expression experiment using small-scale cultures to see if there was expression of the constructs. I designed 69 constructs of USP Zf-UBDs, and chose 17 that expressed well in the TestX and 12 available constructs already in the SGC database that have high expression. Next, I did large scale growth in bacteria and am now working my way through purifying them. Once proteins are pure, I set up crystal trays using our in-house screens. So far, I have identified some crystals for USP20 and USP33 Zf-UBD but they either don’t diffract or need more optimizing (<strong>Table 2</strong>). You can see full experimental details on<a href="https://zenodo.org/record/1473615#.W9cVW2hKjIU"> Zenodo</a>.</p>
<p><strong>Table 2</strong>. Summary of USP Zf-UBD Crystallization Pipeline To Date</p>
<table>
<tbody>
<tr>
<td style="width: 74px;"><strong>Clone </strong></td>
<td style="width: 46px;"><strong>Target</strong></td>
<td style="width: 50px;"><strong>AA </strong></td>
<td style="width: 79px;"><strong>Vector</strong></td>
<td style="width: 37px;"><strong>Media</strong></td>
<td style="width: 61px;"><strong>Amount Grown (L)</strong></td>
<td style="width: 82px;"><strong>Purification Yield (mg) </strong></td>
<td style="width: 56px;"><strong>Crystal Plate Setup (Y/N) </strong></td>
<td style="width: 70px;"><strong>Crystals? (Y/N) </strong></td>
<td style="width: 77px;"><strong>Diffraction (Y/N)</strong></td>
</tr>
<tr>
<td style="width: 74px;">TOC013E09</td>
<td style="width: 46px;">USP44</td>
<td style="width: 50px;">27-110</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">12</td>
<td style="width: 82px;">No/low expression</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013F02</td>
<td style="width: 46px;">USP49</td>
<td style="width: 50px;">15-105</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">12</td>
<td style="width: 82px;">0.25 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D10</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">37-124</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">15.7 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">Y</td>
<td style="width: 77px;">N</td>
</tr>
<tr>
<td style="width: 74px;">TOC013D11</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">38-124</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">0.35 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013E02</td>
<td style="width: 46px;">USP39</td>
<td style="width: 50px;">97-197</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">1.6 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013E05</td>
<td style="width: 46px;">USP39</td>
<td style="width: 50px;">97-205</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C02</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">188-292</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">Insoluble</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C03</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">208-292</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">Insoluble</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C04</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">208-308</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013B11</td>
<td style="width: 46px;">USP03</td>
<td style="width: 50px;">10-152</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C08</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">26-146</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">0.7 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C09</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">32-146</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C11</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">1-100</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">4.8 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D03</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">1-110</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">13.2 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">Y: optimizing</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D04</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">8-110</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013-D07</td>
<td style="width: 46px;">USP22</td>
<td style="width: 50px;">43-142</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">No/low expression</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D08</td>
<td style="width: 46px;">USP22</td>
<td style="width: 50px;">49-142</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;"></td>
<td style="width: 46px;"></td>
<td style="width: 50px;"></td>
<td style="width: 79px;"></td>
<td style="width: 37px;"></td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 803px;" colspan="10">Constructs previously available in SGC database that have high expression:</td>
</tr>
<tr>
<td style="width: 74px;">SDC093D04</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">183-307</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC093D05</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">187-301</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC024F07</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">34-185</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC024F09</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">16-185</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC024F10</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">8-185</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC036B06</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">1-141</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC042G05</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">7-139</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC042G06</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">7-167</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC042G07</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">7-183</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC168E10</td>
<td style="width: 46px;">USP44</td>
<td style="width: 50px;">1-167</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC231F11</td>
<td style="width: 46px;">USP51</td>
<td style="width: 50px;">160-350</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC231-G03</td>
<td style="width: 46px;">USP51</td>
<td style="width: 50px;">176-350</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
</tbody>
</table>
<p>I still have some more constructs to grow and purify and hopefully I’ll be able to crystallize and solve some novel USP Zf-UBDs. More on this later!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screening Compounds of Interest against USP5 Zf-UBD by SPR #2</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/#respond</comments>
		<pubDate>Thu, 04 Oct 2018 15:11:41 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=1962</guid>
		<description><![CDATA[I used a surface plasmon resonance assay to determine the binding affinities of hit compounds that were identified in 19F NMR spectroscopy screens against the zinc finger ubiquitin binding domain of USP5. To see how these assays work, check out some of my previous posts! You can see details of the SPR experiment on Zenodo. <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I used a surface plasmon resonance assay to determine the binding affinities of hit compounds that were identified in <sup>19</sup>F NMR spectroscopy screens against the zinc finger ubiquitin binding domain of USP5. To see how these assays work, check out some of my <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">previous posts</a>! You can see details of the SPR experiment on <a href="https://zenodo.org/record/1445571#.W7YsIWhKjIU">Zenodo</a><strong>.</strong></p>
<p>Compound UBXML78 had the best binding affinity, with a K<sub>D</sub> of approximately 59 µM and a ligand efficiency LE=0.24 (Figure 1). DAT76 (K<sub>D</sub>  ̴ 109 µM) had the best ligand efficiency (LR=0.29) (Figure 2). These compounds are rather weak but together with my <a href="https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/">previous crystal structures</a>, still provide a solid starting point for a hit optimization campaign.</p>
<p><img class=" wp-image-1963 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a-300x110.png" alt="" width="420" height="154" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a-300x110.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a-768x281.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a.png 893w" sizes="(max-width: 420px) 100vw, 420px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Representative binding curve of UBXML78 and USP5 Zf-UBD</p>
<p><img class="wp-image-1964 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598-300x105.png" alt="" width="434" height="152" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598-300x105.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598-768x268.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598.png 924w" sizes="(max-width: 434px) 100vw, 434px" /></p>
<p style="text-align: center;"><strong>Figure 2.</strong> Representative binding curve of DAT76 and USP5 Zf-UBD</p>
<p>Now that I’ve tested all the hit compounds from the <sup>19</sup>F NMR screens using SPR, I wanted to see if I could correlate the <sup>19</sup>F NMR assay results with the SPR binding affinity measurements. I find that a chemical shift greater than 1 ppm in the <sup>19</sup>F NMR assay results in binding affinities less than 400 µM. I can use this cut-off to select compounds for SPR based on the NMR screen. This will limit testing of very weak compounds by SPR.</p>
<p>Next, I’ll be doing hit expansions of a few of the compounds of interest where I will run substructure searches and docking simulations to select commercially available compounds for the next set of screening. This will hopefully increase my understanding of the structure activity relationship (SAR) of the chemical series, which in turn will inform the rational design of more potent USP5 Zf-UBD ligands. Stay tuned!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
